Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorSantoro N.
dc.contributor.authorMooyaart J.E.
dc.contributor.authorDevillier R.
dc.contributor.authorKoc Y.
dc.contributor.authorVydra J.
dc.contributor.authorCastagna L.
dc.contributor.authorGülbas Z.
dc.date.accessioned2024-02-04T13:30:07Z
dc.date.available2024-02-04T13:30:07Z
dc.date.issued2023
dc.identifier.issn02683369
dc.identifier.urihttps://doi.org/10.1038/s41409-022-01855-8
dc.identifier.urihttp://hdl.handle.net/11446/4847
dc.description.abstractThe color coding for our three subsets of patients were not identical in Figure 1 and Figure 2. While the "therapeutic" subset appears in green in both figures, the "pre-emptive" group appears in blue in Figure 1 and in red in Figure 2. Conversely, the "prophylactic" group appears in red in Figure 1, and in blue in Figure 2. The order the three groups appear in the legend is also different. This presentation may be confusing to future readers, and thus we would like to substitute a new version of this two figures where the sole modification is harmonization of the color coding, and of the order in entries in the legend. © The Author(s), under exclusive licence to Springer Nature Limited 2022.en_US
dc.language.isoengen_US
dc.publisherSpringer Natureen_US
dc.relation.ispartofBone Marrow Transplantationen_US
dc.identifier.doi10.1038/s41409-022-01855-8
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjecterratumen_US
dc.titleCorrection: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party (Bone Marrow Transplantation, (2023), 58, 1, (54-60), 10.1038/s41409-022-01839-8)en_US
dc.typeerratumen_US
dc.departmentDBÜen_US
dc.identifier.issue1en_US
dc.identifier.volume58en_US
dc.identifier.startpage119en_US
dc.identifier.endpage120en_US
dc.relation.publicationcategoryDiğeren_US
dc.department-tempSantoro, N., Department of Hematology and Oncology, Ospedale Civile “Santo Spirito”, Pescara, Italy; Mooyaart, J.E., EBMT Statistical Unit, Leiden, Netherlands; Devillier, R., Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer, & Centre de Recherches en Cancérologie de Marseille (CRCM), Inserm UMR 1068, Université d’Aix-Marseille, Marseille, France; Koc, Y., Medicana International Hospital Istanbul, Istanbul, Turkey; Vydra, J., Institute of Hematology and Blood Transfusion, Prague, Czech Republic; Castagna, L., Istituto Clinico Humanitas, Milano, Italy; Gülbas, Z., Anadolu Medical Center Hospital, Kocaeli, Turkey; Martin, J.D., Servicio de Hematología Hospital G. Universitario Gregorio Marañon, Instituto de Investigación sanitaria Gregorio Marañon, Department of Medicine Universidad Complutense, Madrid, Spain; Araujo, M.C., Hospital U. Marqués de Valdecilla, Santander, Spain; Kulagin, A., RM Gorbacheva Research Institute, Pavlov University, St, Petersburg, Russian Federation; Arat, M., Demiroglu Bilim University Istanbul Florence Nightingale Hospital Istanbul, Istanbul, Turkey; Arroyo, C.H., Hospital Universitario Reina Sofia. IMIBIC. University of Cordoba, Cordoba, Spain; Martelli, M.P., Institute of Hematology, Centro Ricerche Emato-Oncologiche, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italen_US
dc.identifier.pmid36517566en_US
dc.identifier.scopus2-s2.0-85143810552en_US
dc.authorscopusid55520609200
dc.authorscopusid58155408200
dc.authorscopusid36614114400
dc.authorscopusid7003300703
dc.authorscopusid26024521100
dc.authorscopusid57220144977
dc.authorscopusid6701449218


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster